|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/07 | |
| C12N 5/16 | |||
| C07D 417/06 | |||
| A61K 31/427 | |||
| A61P 29/00 |
| (11) | Patento numeris | 2591092 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11803961.9 |
| Europos patento paraiškos padavimo data | 2011-05-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/034753 |
| Data | 2011-05-02 |
| (87) | Numeris | WO 2012/005800 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 362363 P | 2010-07-08 | US |
| (72) |
GUPTA, Vineet, US
|
| (73) |
Adhaere Pharamaceuticals, Inc.,
11950 S.W. 72nd Place, Pinecrest, FL 33156,
US
|
| (54) | COMPOUNDS AND METHODS FOR REGULATING INTEGRIN CD11B/CD18 |
| COMPOUNDS AND METHODS FOR REGULATING INTEGRIN CD11B/CD18 |